AAPL308.91-24.52 (-7.35%) ▼|ABBV250.94-6.47 (-2.51%) ▼|ABT105.70+0.09 (+0.09%) ▲|ACN165.92+2.63 (+1.61%) ▲|ADBE250.41+2.51 (+1.01%) ▲|AMAT507.67+5.90 (+1.18%) ▲|AMD476.15-9.24 (-1.90%) ▼|AMGN385.16-2.48 (-0.64%) ▼|AMT173.36-1.10 (-0.63%) ▼|AMZN271.58+36.08 (+15.32%) ▲|AVGO389.28+1.44 (+0.37%) ▲|AXP336.25-1.27 (-0.38%) ▼|BA216.14-4.76 (-2.15%) ▼|BAC61.95+0.22 (+0.36%) ▲|BKNG192.90-0.34 (-0.18%) ▼|BLK1,090.39-7.98 (-0.73%) ▼|BMY65.31+0.45 (+0.69%) ▲|BNY156.33+0.25 (+0.16%) ▲|BRK-B511.54+1.86 (+0.36%) ▲|C132.45+0.13 (+0.10%) ▲|CAT814.81+5.67 (+0.70%) ▲|CL91.30-0.30 (-0.33%) ▼|CMCSA23.96+0.29 (+1.23%) ▲|COF209.01-1.13 (-0.54%) ▼|COP120.48+1.45 (+1.22%) ▲|COST951.89-2.28 (-0.24%) ▼|CRM184.02+3.31 (+1.83%) ▲|CSCO115.99+2.43 (+2.14%) ▲|CVS104.43-0.79 (-0.75%) ▼|CVX196.83+4.52 (+2.35%) ▲|DE592.67-6.80 (-1.13%) ▼|DHR194.98-1.19 (-0.61%) ▼|DIS96.19+0.03 (+0.03%) ▲|DUK125.43-0.84 (-0.67%) ▼|EMR149.82+1.18 (+0.79%) ▲|FDX307.40-1.15 (-0.37%) ▼|GD383.42+1.22 (+0.32%) ▲|GE360.07+5.03 (+1.42%) ▲|GEV990.29+8.31 (+0.85%) ▲|GILD130.21-1.07 (-0.82%) ▼|GM88.86+0.46 (+0.52%) ▲|GOOG356.65+22.97 (+6.88%) ▲|GOOGL356.13+22.47 (+6.73%) ▲|GS1,018.38-6.48 (-0.63%) ▼|HD331.96-1.39 (-0.42%) ▼|HON243.05+1.14 (+0.47%) ▲|IBM223.65+1.91 (+0.86%) ▲|INTC90.20-0.93 (-1.02%) ▼|INTU316.07+0.57 (+0.18%) ▲|ISRG353.33+0.36 (+0.10%) ▲|JNJ256.35+0.53 (+0.21%) ▲|JPM351.79+0.94 (+0.27%) ▲|KO87.59-0.90 (-1.02%) ▼|LIN478.38-30.26 (-5.95%) ▼|LLY1,148.84-6.13 (-0.53%) ▼|LMT582.74+8.63 (+1.50%) ▲|LOW207.81-2.27 (-1.08%) ▼|LRCX293.02-4.70 (-1.58%) ▼|MA573.10-4.25 (-0.74%) ▼|MCD270.64+2.20 (+0.82%) ▲|MDLZ62.31-0.77 (-1.22%) ▼|MDT85.39-0.32 (-0.37%) ▼|META556.71+17.68 (+3.28%) ▲|MMM176.28+0.21 (+0.12%) ▲|MO68.33+0.39 (+0.57%) ▲|MRK130.20+0.41 (+0.32%) ▲|MS210.42+1.51 (+0.72%) ▲|MSFT464.72+13.62 (+3.02%) ▲|MU823.03-51.63 (-5.90%) ▼|NEE86.92-1.01 (-1.15%) ▼|NFLX71.71-1.46 (-2.00%) ▼|NKE41.71-0.58 (-1.37%) ▼|NOW111.23+1.16 (+1.05%) ▲|NVDA200.75+5.71 (+2.93%) ▲|ORCL129.87+2.31 (+1.81%) ▲|PEP139.56-0.64 (-0.46%) ▼|PFE25.01+0.10 (+0.40%) ▲|PG144.49+0.53 (+0.37%) ▲|PLTR123.06+0.80 (+0.65%) ▲|PM190.82-1.18 (-0.61%) ▼|QCOM147.61-3.99 (-2.63%) ▼|RTX215.22+0.84 (+0.39%) ▲|SBUX105.25-0.60 (-0.57%) ▼|SCHW105.24+0.91 (+0.87%) ▲|SO94.54+0.20 (+0.21%) ▲|SPG229.37-1.07 (-0.46%) ▼|T23.25+0.04 (+0.17%) ▲|TMO574.30-2.47 (-0.43%) ▼|TMUS172.71-0.63 (-0.36%) ▼|TSLA311.21+2.36 (+0.76%) ▲|TXN275.74-3.02 (-1.08%) ▼|UBER70.36-0.01 (-0.01%) ▼|UNH414.40-7.07 (-1.68%) ▼|UNP292.13+2.67 (+0.92%) ▲|UPS104.22-1.05 (-1.00%) ▼|USB63.01+0.11 (+0.17%) ▲|V366.13-0.14 (-0.04%) ▼|VZ46.81+0.70 (+1.52%) ▲|WFC86.45+1.02 (+1.19%) ▲|WMT111.20+0.10 (+0.09%) ▲|XOM155.44-1.53 (-0.97%) ▼|AAPL308.91-24.52 (-7.35%) ▼|ABBV250.94-6.47 (-2.51%) ▼|ABT105.70+0.09 (+0.09%) ▲|ACN165.92+2.63 (+1.61%) ▲|ADBE250.41+2.51 (+1.01%) ▲|AMAT507.67+5.90 (+1.18%) ▲|AMD476.15-9.24 (-1.90%) ▼|AMGN385.16-2.48 (-0.64%) ▼|AMT173.36-1.10 (-0.63%) ▼|AMZN271.58+36.08 (+15.32%) ▲|AVGO389.28+1.44 (+0.37%) ▲|AXP336.25-1.27 (-0.38%) ▼|BA216.14-4.76 (-2.15%) ▼|BAC61.95+0.22 (+0.36%) ▲|BKNG192.90-0.34 (-0.18%) ▼|BLK1,090.39-7.98 (-0.73%) ▼|BMY65.31+0.45 (+0.69%) ▲|BNY156.33+0.25 (+0.16%) ▲|BRK-B511.54+1.86 (+0.36%) ▲|C132.45+0.13 (+0.10%) ▲|CAT814.81+5.67 (+0.70%) ▲|CL91.30-0.30 (-0.33%) ▼|CMCSA23.96+0.29 (+1.23%) ▲|COF209.01-1.13 (-0.54%) ▼|COP120.48+1.45 (+1.22%) ▲|COST951.89-2.28 (-0.24%) ▼|CRM184.02+3.31 (+1.83%) ▲|CSCO115.99+2.43 (+2.14%) ▲|CVS104.43-0.79 (-0.75%) ▼|CVX196.83+4.52 (+2.35%) ▲|DE592.67-6.80 (-1.13%) ▼|DHR194.98-1.19 (-0.61%) ▼|DIS96.19+0.03 (+0.03%) ▲|DUK125.43-0.84 (-0.67%) ▼|EMR149.82+1.18 (+0.79%) ▲|FDX307.40-1.15 (-0.37%) ▼|GD383.42+1.22 (+0.32%) ▲|GE360.07+5.03 (+1.42%) ▲|GEV990.29+8.31 (+0.85%) ▲|GILD130.21-1.07 (-0.82%) ▼|GM88.86+0.46 (+0.52%) ▲|GOOG356.65+22.97 (+6.88%) ▲|GOOGL356.13+22.47 (+6.73%) ▲|GS1,018.38-6.48 (-0.63%) ▼|HD331.96-1.39 (-0.42%) ▼|HON243.05+1.14 (+0.47%) ▲|IBM223.65+1.91 (+0.86%) ▲|INTC90.20-0.93 (-1.02%) ▼|INTU316.07+0.57 (+0.18%) ▲|ISRG353.33+0.36 (+0.10%) ▲|JNJ256.35+0.53 (+0.21%) ▲|JPM351.79+0.94 (+0.27%) ▲|KO87.59-0.90 (-1.02%) ▼|LIN478.38-30.26 (-5.95%) ▼|LLY1,148.84-6.13 (-0.53%) ▼|LMT582.74+8.63 (+1.50%) ▲|LOW207.81-2.27 (-1.08%) ▼|LRCX293.02-4.70 (-1.58%) ▼|MA573.10-4.25 (-0.74%) ▼|MCD270.64+2.20 (+0.82%) ▲|MDLZ62.31-0.77 (-1.22%) ▼|MDT85.39-0.32 (-0.37%) ▼|META556.71+17.68 (+3.28%) ▲|MMM176.28+0.21 (+0.12%) ▲|MO68.33+0.39 (+0.57%) ▲|MRK130.20+0.41 (+0.32%) ▲|MS210.42+1.51 (+0.72%) ▲|MSFT464.72+13.62 (+3.02%) ▲|MU823.03-51.63 (-5.90%) ▼|NEE86.92-1.01 (-1.15%) ▼|NFLX71.71-1.46 (-2.00%) ▼|NKE41.71-0.58 (-1.37%) ▼|NOW111.23+1.16 (+1.05%) ▲|NVDA200.75+5.71 (+2.93%) ▲|ORCL129.87+2.31 (+1.81%) ▲|PEP139.56-0.64 (-0.46%) ▼|PFE25.01+0.10 (+0.40%) ▲|PG144.49+0.53 (+0.37%) ▲|PLTR123.06+0.80 (+0.65%) ▲|PM190.82-1.18 (-0.61%) ▼|QCOM147.61-3.99 (-2.63%) ▼|RTX215.22+0.84 (+0.39%) ▲|SBUX105.25-0.60 (-0.57%) ▼|SCHW105.24+0.91 (+0.87%) ▲|SO94.54+0.20 (+0.21%) ▲|SPG229.37-1.07 (-0.46%) ▼|T23.25+0.04 (+0.17%) ▲|TMO574.30-2.47 (-0.43%) ▼|TMUS172.71-0.63 (-0.36%) ▼|TSLA311.21+2.36 (+0.76%) ▲|TXN275.74-3.02 (-1.08%) ▼|UBER70.36-0.01 (-0.01%) ▼|UNH414.40-7.07 (-1.68%) ▼|UNP292.13+2.67 (+0.92%) ▲|UPS104.22-1.05 (-1.00%) ▼|USB63.01+0.11 (+0.17%) ▲|V366.13-0.14 (-0.04%) ▼|VZ46.81+0.70 (+1.52%) ▲|WFC86.45+1.02 (+1.19%) ▲|WMT111.20+0.10 (+0.09%) ▲|XOM155.44-1.53 (-0.97%) ▼|
30.8 C
New York
Saturday, August 1, 2026

Tag: Nasdaq:LRMR

newssourceFORcompanyinformationcontent1releasesmarket

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia

BALA CYNWYD, Pa., June 26, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that the Company will host an investor event to discuss updates for the Company’s nomlabofusp clinical development program including a regulatory update and data from the ongoing long-term open label study for the treatment of Friedreich’s ataxia on Monday, June 29, 2026 at 7:45 am ET.

Larimar Therapeutics Announces Pricing of Underwritten Public Offering

BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the pricing of its previously announced underwritten public offering of 18,750,000 shares of its common stock at a price to the public of $3.20 per share. The aggregate gross proceeds to Larimar from this offering are expected to be $60.0 million, before deducting underwriting discounts and commissions and other offering expenses. In addition, Larimar has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 shares of its common stock at the public offering price, less underwriting discounts and commissions. All shares of common stock are being offered by Larimar. The offering is expected to close on or about July 31, 2025, subject to the satisfaction of customary closing conditions.

Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia

Conference call and webcast on Monday, June 23, 2025 at 8:00 am EDT 
Conference call and webcast on Monday, June 23, 2025 at 8:00 am EDT

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsNasdaq:LRMR

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers